title: Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease.
abstract: BACKGROUND
  Recurrent and painful genital ulcers are the hallmark of Behçet's disease.
  
  
  OBJECTIVE
  To determine the efficacy of pimecrolimus (PIM) cream on the pain and healing time of genital ulcers.
  
  
  METHODS
  A total of 76 patients were randomized to either receive PIM cream plus colchicine (COL) tablets (1-2 g/day) or COL tablets (1-2 g/day) alone for 1 month. Clinical evaluations were performed in 68 patients at the baseline and on the 3rd, 7th, 10th, 14th and 28th days of treatment. Also, genital ulcer pain was evaluated using a verbal pain score at each visit. Safety was monitored through adverse event reporting and laboratory tests.
  
  
  RESULTS
  The mean healing time of genital ulcers was shorter in the PIM + COL group (4.2 +/- 1.5 days) than the COL group (4.7 +/- 1.8 days), without statistical significance (p = 0.399). Visual analog scale scores decreased in both groups significantly. Neither of the treatment modalities was found to be superior to the other; however, pain was relieved in 4.2 +/- 0.5 days in PIM + COL group and in 5.5 +/- 1.2 days in COL group in the intention to treat population (p = 0.023). Observed adverse events were transient.
  
  
  CONCLUSIONS
  Compared to COL alone, COL + PIM cream shortens the pain duration without any significant effect on healing time.
authors.affiliation: Department of Dermatology, Gulhane School of Medicine, Ankara, Turkey. okose@gata.edu.tr
authors.forename: Osman
authors.initials: O
authors.lastname: Köse
authors.forename: Ayhan
authors.initials: A
authors.lastname: Dinç
authors.forename: Ismail
authors.initials: I
authors.lastname: Simşek
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000150:complications*; D003078:Colchicine / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004643:Emollients / Q000008:administration & dosage; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000473:pathology; D005832:Genital Diseases, Male / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010147:Pain Measurement; D012189:Retrospective Studies; D012611:Scrotum / Q000473:pathology; D013607:Tablets / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014421:Turkey; D014456:Ulcer / Q000188:drug therapy* / Q000209:etiology; D014621:Vagina / Q000473:pathology
chemical_list: D003879:Dermatologic Agents; D004643:Emollients; D013607:Tablets; C117268:pimecrolimus; D003078:Colchicine; D016559:Tacrolimus